logo-loader
viewDyadic International Inc

Dyadic International Inc stock ticks up on partnership announcement

Dyadic International Inc (OTCQX:DYAI) CEO Mark Emalfarb sat down with Proactive Investors' Christine Corrado at the Bio Investor Forum in San Francisco.

Proactive previously interviewed Ping Rawson about the company at the MicroCap Conference in October. 

Dyadic International is a global biotechnology company focused on further improving and applying the proprietary C1 expression system to help drug developers and manufacturers bring biologic drugs to market faster, in greater volumes, at lower cost, and with new properties that will improve access and cost to patients and the healthcare system.

Quick facts: Dyadic International Inc

Price: 5.875 USD

NASDAQ:DYAI
Market: NASDAQ
Market Cap: $162.34 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Dyadic International Inc named herein, including the promotion by the Company of Dyadic International Inc in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Dyadic working with global research partners to express potential...

Dyadic International Inc (NASDAQ:DYAI) CEO Mark Emalfarb tells Proactive the Florida-based biotech is 'delivering on its promises.' Emalfarb says it saw a busy first quarter where the company stepped up in the global fight against the coronavirus pandemic. Emalfarb says among its recent...

1 week, 5 days ago

2 min read